Enrique Velazquez Villarreal, MD, PhD, MPH, MS, reveals how AI is being used to identify early-onset CRC and enhance ...
Ibex's high-performance AI platform--already deployed across more than 50 health systems worldwide and used in collaboration with major industry organizations such as Philips and Roche--now supports ...
BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated with glufosfamide. The study revealed four patient clusters, with one ...
Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...
The European voice/vocal biomarker market is positioned for substantial growth, reaching $1.69 billion by 2035 from $335.2 million in 2024, at a CAGR of 16%. Utilized for non-invasive health ...
Biomarkers are quantifiable compounds that can determine human health status and potentially detect the presence of disease in the body. In clinical settings, routine procedures detect, measure, and ...
New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.
The identification of unique pulmonary fibrosis endotypes is an important step in the development of precision medicine approaches for the incurable condition. Three distinct blood biomarker ...
The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine’s Center for Space Medicine, with consortium partners California Institute of Technology and Massachusetts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback